The S100A8/A9 heterodimer has been shown to be a reliable indicator of disease activity and joint inflammation in inflammatory rheumatic diseases, including RA [18,19], juvenile RA (JRA) [27-30], psoriatic arthritis [18], and spondylarthropathy [18]. This evidence concerns the gene S100A8 and psoriatic arthritis.